XT
ANEB

XTX Topco’s Anebulo Pharmaceuticals ANEB Stock Holding History

XTX Topco’s Portfolio ANEB Stock Details ANEB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,153
Closed -$47.9K – 3285
2025
Q3 		$47.9K Buy
+19,153
New +$45.1K ﹤0.01% 2182

Other funds holding ANEB

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco's ANEB Position: Q4 2025 in Review

XTX Topco sold out of Anebulo Pharmaceuticals (ANEB) in Q4 2025, closing a stake of 19,153 shares — an estimated $47.9K sold.

XTX Topco first reported a position in ANEB in Q3 2025 and held it in 1 quarter. The position peaked at $47.9K in Q3 2025. 19 funds tracked by Wall St. Rank hold ANEB as of Q4 2025.

  • XTX Topco reported no remaining Anebulo Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 19,153 Anebulo Pharmaceuticals shares in Q4 2025, an estimated $47.9K.
  • XTX Topco first reported a position in Anebulo Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • XTX Topco's Anebulo Pharmaceuticals position peaked at $47.9K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Anebulo Pharmaceuticals as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.